Stephen L. Schmidt - Publications

Psychiatry University of North Carolina, Chapel Hill, Chapel Hill, NC 
Networks , Pharmacology,

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.


Year Citation  Score
2018 Negahbani E, Schmidt SL, Mishal N, Fröhlich F. Neuromodulation-dependent effect of gated high-frequency, LFMS-like electric field stimulation in mouse cortical slices. The European Journal of Neuroscience. PMID 30450622 DOI: 10.1111/ejn.14273  0.64
2016 Schmidt SL, Dorsett CR, Iyengar AK, Fröhlich F. Interaction of Intrinsic and Synaptic Currents Mediate Network Resonance Driven by Layer V Pyramidal Cells. Cerebral Cortex (New York, N.Y. : 1991). PMID 27578493 DOI: 10.1093/cercor/bhw242  0.64
2016 Alagapan S, Schmidt SL, Lefebvre J, Hadar E, Shin HW, Frӧhlich F. Modulation of Cortical Oscillations by Low-Frequency Direct Cortical Stimulation Is State-Dependent. Plos Biology. 14: e1002424. PMID 27023427 DOI: 10.1371/journal.pbio.1002424  0.8
2015 Köhler W, Ehrlich S, Dohmen C, Haubitz M, Hoffmann F, Schmidt S, Klingel R, Kraft A, Neumann-Haefelin T, Topka H, Stich O, Baumgartner A, Fassbender C. Tryptophan immunoadsorption for the treatment of autoimmune encephalitis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 203-6. PMID 24589025 DOI: 10.1111/ene.12389  0.8
2015 Wonneberger M, Schmidt S. Endurance exercise in multiple sclerosis – exercise activity in dependency on the severity of fatigue | Ausdauertraining bei multiple sklerose – trainingsaktivität in abhängigkeit des schweregrads der fatigue Deutsche Zeitschrift Fur Sportmedizin. 66: 92-97. DOI: 10.5960/dzsm.2015.168  0.8
2015 Wonneberger M, Schmidt S. Changes of gait parameters following long-term aerobic endurance exercise in mildly disabled multiple sclerosis patients: An exploratory study European Journal of Physical and Rehabilitation Medicine. 51: 755-762.  0.8
2015 Gold R, Gass A, Haupts M, Linker R, Lukas C, Mäurer M, Stangel M, Tackenberg B, Ziemssen T, Wiendl H, Hartung HP, Haas J, Harms L, Honig H, Kallmann B, ... ... Schmidt S, et al. Therapy and management of relapsing-remitting multiple sclerosis | Therapieziele und Therapie - management bei schubförmigremittierender Multipler Sklerose Nervenheilkunde. 34: 915-923.  0.8
2014 Schmidt SL, Iyengar AK, Foulser AA, Boyle MR, Fröhlich F. Endogenous cortical oscillations constrain neuromodulation by weak electric fields. Brain Stimulation. 7: 878-89. PMID 25129402 DOI: 10.1016/j.brs.2014.07.033  0.8
2014 Hammad M, Schmidt SL, Zhang X, Bray R, Frohlich F, Ghashghaei HT. Transplantation of GABAergic Interneurons into the Neonatal Primary Visual Cortex Reduces Absence Seizures in Stargazer Mice. Cerebral Cortex (New York, N.Y. : 1991). PMID 24812085 DOI: 10.1093/cercor/bhu094  0.8
2014 Frischer J, Reindl M, Künz B, Berger T, Schmidt S, Milford E, Knosp E, Lassmann H, Utku N. TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 24526664 DOI: 10.1177/1352458514521516  0.8
2014 Schmidt S, Wonneberger M. Long-term endurance exercise improves aerobic capacity in patients with relapsing-remitting Multiple Sclerosis: Impact of baseline fatigue Journal of the Neurological Sciences. 336: 29-35. PMID 24139841 DOI: 10.1016/j.jns.2013.09.035  0.8
2013 Fröhlich F, Schmidt SL. Rational design of transcranial current stimulation (TCS) through mechanistic insights into cortical network dynamics. Frontiers in Human Neuroscience. 7: 804. PMID 24324427 DOI: 10.3389/fnhum.2013.00804  0.8
2013 Schmidt SL, Chew EY, Bennett DV, Hammad MA, Fröhlich F. Differential effects of cholinergic and noradrenergic neuromodulation on spontaneous cortical network dynamics. Neuropharmacology. 72: 259-73. PMID 23643755 DOI: 10.1016/j.neuropharm.2013.04.045  0.8
2013 Schmidt S. Fampridine improves severe dysarthria in secondary-progressive multiple sclerosis Multiple Sclerosis Journal. 19: 511. DOI: 10.1177/1352458512458554  0.8
2013 Schmidt SL, Foulser AA, Frohlich F. Brain stimulation by network resonance with weak electric fields probed by optogenetics in vitro International Ieee/Embs Conference On Neural Engineering, Ner. 1186-1189. DOI: 10.1109/NER.2013.6696151  0.8
2012 Warnke C, Dehmel T, Posevitz-Fejfár A, Chan A, Berthele A, Schmidt S, Haas J, Kronsbein HC, Seitz F, Tackenberg B, Mäurer M, Gerbershagen K, Limmroth V, Adams O, Hartung HP, et al. Anti-JC-virus antibody prevalence in a German MS cohort. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1054-5. PMID 22740609 DOI: 10.1177/1352458511429955  0.8
2012 Wonneberger M, Drogge D, Schmidt S, Froböse I. Changes of gait parameters in female multiple sclerosis patients after an endurance training | Veränderung von gangparametern weiblicher multiple sklerose patienten nach einem ausdauertraining Deutsche Zeitschrift Fur Sportmedizin. 63: 143-147. DOI: 10.5960/dzsm.2012.013  0.8
2012 Schimrigk S, Adibi I, Eberl A, Selka I, Galle J, Schmidt S, Fritz HG, Fassbender C, Klingel R, Füchtemann D, Hoffmann F. Immunoadsorption as relapse escalation therapy for multiple sclerosis | Immunadsorption zur Eskalation der Schubtherapie bei Multipler Sklerose Aktuelle Neurologie. 39: 174-179. DOI: 10.1055/s-0032-1305029  0.8
2012 Schmidt S. Successful long-term treatment of relapsing-remitting multiple sclerosis with interferon β-1b | Erfolgreiche Langzeittherapie der schubförmigen Multiplen Sklerose mit Interferon β-1b Aktuelle Neurologie, Supplement. 39: S22-S23. DOI: 10.1055/s-0032-1304863  0.8
2011 Schmidt S, Wattjes MP, Gerding WM, Van Der Knaap M. Late onset alexander's disease presenting as cerebellar ataxia associated with a novel mutation in the GFAP gene Journal of Neurology. 258: 938-940. PMID 21165639 DOI: 10.1007/s00415-010-5849-0  0.8
2010 Schmidt S. Oral cladribine for relapsing-remitting multiple sclerosis: Another purine analogue or a genuine therapeutic innovation? | Cladribin-tabletten bei schubförmiger multipler sklerose: Noch ein purinanalogon oder echte therapeutische innovation? Nervenarzt. 81: 1231-1241. PMID 20567960 DOI: 10.1007/s00115-010-3040-6  0.8
2010 Simon B, Schmidt S, Lukas C, Gieseke J, Träber F, Knol DL, Willinek WA, Geurts JJ, Schild HH, Barkhof F, Wattjes MP. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. European Radiology. 20: 1675-83. PMID 20094887 DOI: 10.1007/s00330-009-1705-y  0.8
2009 Klotz L, Schmidt S, Heun R, Klockgether T, Kölsch H. Association of the PPARγ gene polymorphism Pro12Ala with delayed onset of multiple sclerosis Neuroscience Letters. 449: 81-83. PMID 18977277 DOI: 10.1016/j.neulet.2008.10.066  0.8
2009 Gold R, Hartung HP, Hohlfeld R, Wiendl H, Kieseier BC, Linker RA, Schmidt S, Toyka KV, Adams O, Baum K, Bayas A, Bitsch A, Buck D, Chan A, Derfuß T, et al. Therapy of multiple sclerosis with monoclonal antibodies: Results and recommendations of a symposium of the medical advisory board of the german MS society | Therapie der multiplen sklerose mit monoklonalen antikörpern: Ergebnisse und empfehlungen einer arbeitstagung des ärztlichen beirats der deutschen multiple sklerose gesellschaft Aktuelle Neurologie. 36: 334-344. DOI: 10.1055/s-0029-1220429  0.8
2008 Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, ... ... Schmidt S, et al. Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations Journal of Neurology. 255: 1449-1463. PMID 19005625 DOI: 10.1007/s00415-008-0061-1  0.8
2008 Wattjes MP, Harzheim M, Lutterbey GG, Hojati F, Simon B, Schmidt S, Schild HH, Barkhof F. Does high field MRI allow an earlier diagnosis of multiple sclerosis? Journal of Neurology. 255: 1159-63. PMID 18446305 DOI: 10.1007/s00415-008-0861-3  0.8
2008 Wattjes MP, Harzheim M, Lutterbey GG, Bogdanow M, Schmidt S, Schild HH, Träber F. Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis Neuroradiology. 50: 123-129. PMID 17982745 DOI: 10.1007/s00234-007-0325-y  0.8
2008 Ries S, Elias WG, Japp G, Lang M, Bergmann A, Bischoff C, Hofmann W, Kausch U, Reifschneider G, Mager, Weber, Albrecht, Butz, Bittkau F, Bode, ... ... Schmidt S, et al. Improvement of adherence in MS therapy - Results of an MS therapy support study | Steigerung der therapietreue durch ein therapie-begleitprogramm bei multipler sklerose Nervenheilkunde. 27: 818-822.  0.8
2007 Wattjes MP, Lutterbey GG, Gieseke J, Träber F, Klotz L, Schmidt S, Schild HH. Double inversion recovery brain imaging at 3T: Diagnostic value in the detection of multiple sclerosis lesions American Journal of Neuroradiology. 28: 54-59. PMID 17213424  0.8
2006 Sbeity ZH, Baydoun L, Schmidt S, Loeffler KU. Visual field changes in methotrexate therapy: Case report and review of the literature Journal Medical Libanais. 54: 164-167. PMID 17190135  0.8
2006 Wattjes MP, Harzheim M, Kuhl CK, Gieseke J, Schmidt S, Klotz L, Klockgether T, Schild HH, Lutterbey GG. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR imaging criteria for multiple sclerosis? American Journal of Neuroradiology. 27: 1794-1798. PMID 16971638  0.8
2006 Linnebank M, Semmler A, Kleijer WJ, van der Sterre ML, Gärtner J, Fliessbach K, Sokolowski P, Köhler W, Schlegel U, Klockgether T, Wanders RJ, Schmidt S, Wüllner U, Kemp S. The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy. Human Mutation. 27: 1063-4. PMID 16941496 DOI: 10.1002/humu.9459  0.8
2006 Zeitler H, Ulrich-Merzenich G, Hoffmann L, Kornblum C, Schmidt S, Vetter H, Walger P. Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis Artificial Organs. 30: 597-605. PMID 16911313 DOI: 10.1111/j.1525-1594.2006.00268.x  0.8
2006 Linnebank M, Kemp S, Wanders RJ, Kleijer WJ, van der Sterre ML, Gärtner J, Fliessbach K, Semmler A, Sokolowski P, Köhler W, Schlegel U, Schmidt S, Klockgether T, Wüllner U. Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy. Neurology. 66: 442-3. PMID 16476952 DOI: 10.1212/01.wnl.0000196491.42058.6f  0.8
2004 Harzheim M, Stepien-Mering M, Schröder R, Schmidt S. The expression of microfilament-associated cell-cell contacts in brain endothelial cells is modified by IFN-β1a (Rebif®) Journal of Interferon and Cytokine Research. 24: 711-716. PMID 15684738 DOI: 10.1089/1079990042722855  0.8
2004 Fischer D, Grothe C, Schmidt S, Schröder R. On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy Journal of Neurology. 251: 1204-1207. PMID 15503098 DOI: 10.1007/s00415-004-0507-z  0.8
2004 Linnebank M, Schmidt S, Kölsch H, Linnebank A, Heun R, Schmidt-Wolf IGH, Glasmacher A, Fliessbach K, Klockgether T, Schlegel U, Pels H. The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma British Journal of Cancer. 90: 1969-1971. PMID 15138479 DOI: 10.1038/sj.bjc.6601777  0.8
2004 Schmidt S, Schneider T, Schmidt-Wolf I, Ko Y, Schlegel U, Klockgether T, Hertfelder HJ. C1-inhibitor activity and plasma concentrations in patients with monoclonal gammopathies: Implications for treatment with recombinant interferon-beta 1b Multiple Sclerosis. 10: 243-244. PMID 15124772 DOI: 10.1191/1352458504ms999xx  0.8
2004 Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, Wekerle H, Hohlfeld R, Goebels N. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proceedings of the National Academy of Sciences of the United States of America. 101: 2428-33. PMID 14983026 DOI: 10.1073/pnas.0308689100  0.8
2004 Harzheim M, Schlegel U, Urbach H, Klockgether T, Schmidt S. Discriminatory features of acute transverse myelitis: A retrospective analysis of 45 patients Journal of the Neurological Sciences. 217: 217-223. PMID 14706227 DOI: 10.1016/j.jns.2003.10.009  0.8
2004 Schmidt S, Moric E, Schmidt M, Sastre M, Feinstein DL, Heneka MT. Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients. Journal of Leukocyte Biology. 75: 478-85. PMID 14657213 DOI: 10.1189/jlb.0803402  0.8
2003 Linnebank M, Kesper K, Jeub M, Urbach H, Wüllner U, Klockgether T, Schmidt S. Hereditary elevation of angiotensin converting enzyme suggesting neurosarcoidosis Neurology. 61: 1819-1820. PMID 14694062  0.8
2003 Paus S, Prömse A, Schmidt S, Klockgether T, Mao-Draayer Y, Panitch H. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange [1] (multiple letters) Neurology. 61: 1022. PMID 14557593  0.8
2003 Harzheim M, Altenschmidt M, Heneka MT, Schröder R, Klockgether T, Schmidt S. IFN-beta1a (Rebif) modifies the expression of microfilament-associated cell-cell contacts in C6 glioma cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 23: 83-9. PMID 12744773 DOI: 10.1089/107999003321455471  0.8
2003 Schmidt S, Papassotiropoulos A, Sotgiu S, Kölsch H, Arru G, Fois ML, Haase CG, Schmitz S, König N, Harzheim M, Heun R, Klockgether T. Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis Journal of Neurology. 250: 607-611. PMID 12736743 DOI: 10.1007/s00415-003-1051-y  0.8
2003 Moskau S, Urbach H, Hartmann A, Schmidt S. Multifocal myelitis in Behçet's disease Neurology. 60: 517. PMID 12578943  0.8
2003 Schmidt S, Marrosu GM, Kölsch H, Haase CG, Ferenczik S, Sokolowski P, Köhler W, Schmidt M, Papassotiropoulos A, Heun R, Grosse-Wilde H, Klockgether T. Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy. Journal of Neuroimmunology. 135: 148-53. PMID 12576235 DOI: 10.1016/S0165-5728(02)00445-9  0.8
2003 Hirsch O, Lehmann W, Corth M, Röhrle B, Schmidt S, Schipper HI. Mental imagery, motor imagery and mental rotation in patients with Parkinson's Disease | Visuelle Vorstellungsfähigkeit, Bewegungsvorstellung und mentales Rotieren bei Morbus Parkinson Zeitschrift Fur Neuropsychologie. 14: 67-80. DOI: 10.1024//1016-264X.14.2.67  0.8
2002 Fischer D, Reimann J, Schröder R, Schmidt S. Multitocal motor neuropathy: Diagnosis and differential diagnosis | Die multifokale motorische neuropathie: Diagnose und differentialdiagnose Nervenarzt. 73: 1153-1159. PMID 12486564 DOI: 10.1007/s00115-002-1440-y  0.8
2002 Haase CG, Schmidt S, Faustmann PM. Frequencies of the G-protein β3 subunit C825T polymorphism and the δ 32 mutation of the chemokine receptor-5 in patients with multiple sclerosis Neuroscience Letters. 330: 293-295. PMID 12270649 DOI: 10.1016/S0304-3940(02)00807-8  0.8
2002 Rieckmann P, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, ... ... Schmidt S, et al. Escalating immunomodulatory therapy of multiple sclerosis - New aspects and practical application | Immunmodulatorische stufentherapie der multiplen sklerose: Neue aspekte und praktische umsetzung, März 2002 Nervenarzt. 73: 556-563. PMID 12243005 DOI: 10.1007/s00115-002-1328-x  0.8
2002 Schmidt S, Balzer S, Nüllen C, Schmidt M, Pohl C, Von Rücker A, Klockgether T. Immunomodulatory effects of glatiramer acetate on superantigen- and mitogen-induced T-cell stimulation in vitro Multiple Sclerosis. 8: 307-309. DOI: 10.1191/1352458502ms818sr  0.8
2001 Schmidt S, Haase CG, Bezman L, Moser H, Schmidt M, Köhler W, Linington C, Klockgether T. Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis. Journal of Neuroimmunology. 119: 88-94. PMID 11525804 DOI: 10.1016/S0165-5728(01)00345-9  0.8
2001 Schmidt S, Wessels L, Augustin A, Klockgether T. Patients with Multiple Sclerosis and concomitant uveitis/periphlebitis retinae are not distinct from those without intraocular inflammation Journal of the Neurological Sciences. 187: 49-53. PMID 11440744 DOI: 10.1016/S0022-510X(01)00520-2  0.8
2001 Haase CG, Schmidt S. Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100β and myelin basic protein in patients with Devic's neuromyelitis optica Neuroscience Letters. 307: 131-133. PMID 11427318 DOI: 10.1016/S0304-3940(01)01949-8  0.8
2001 Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, Lamerichs R, Schild H, Klockgether T. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis Archives of Neurology. 58: 729-735. PMID 11346367  0.8
2001 Schmidt S, Träber F, Block W, Keller E, Pohl C, Von Oertzen J, Schild H, Schlegel U, Klockgether T. Phenotype assignment in symptomatic female carriers of X-linked adrenoleukodystrophy Journal of Neurology. 248: 36-44. PMID 11266018 DOI: 10.1007/s004150170267  0.8
2001 Büttner U, Chofflon M, Hess K, Kappos L, Kesselring J, Ludin HP, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Freimüller M, Hartung HP, Kollegger H, Kristoferitsch W, ... ... Schmidt S, et al. Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement | Immunmodulatorische stufentherapie der multiplen sklerose. 1. Ergänzung: Dezember 2000 Nervenarzt. 72: 150-157. PMID 11256151 DOI: 10.1007/s001150050729  0.8
2001 Pohl C, Block W, Träber F, Schmidt S, Pels H, Grothe C, Schild HH, Klockgether T. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients Journal of the Neurological Sciences. 190: 21-27.  0.8
2000 Schmidt S, Papassotiropoulos A, Bagli M, Harzheim M, Heun R, Klockgether T. No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3'flanking region of the interleukin-6 gene in patients with multiple sclerosis Neuroscience Letters. 294: 139-142. PMID 11072134 DOI: 10.1016/S0304-3940(00)01560-3  0.8
2000 Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schröder R, Deckert M, Schmidt S, Ravid R, Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. The Journal of Experimental Medicine. 192: 393-404. PMID 10934227 DOI: 10.1084/jem.192.3.393  0.8
2000 Goebels N, Hofstetter H, Schmidt S, Brunner C, Wekerle H, Hohlfeld R. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain : a Journal of Neurology. 123: 508-18. PMID 10686174  0.8
1999 Schröder R, Keller E, Flacke S, Schmidt S, Pohl C, Klockgether T, Schlegel U. MRI findings in Hirayama's disease: Flexion-induced cervical myelopathy or intrinsic motor neuron disease? Journal of Neurology. 246: 1069-1074. PMID 10631640 DOI: 10.1007/s004150050514  0.8
1999 Padberg F, Feneberg W, Schmidt S, Schwarz MJ, Körschenhausen D, Greenberg BD, Nolde T, Müller N, Trapmann H, König N, Möller HJ, Hampel H. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. Journal of Neuroimmunology. 99: 218-23. PMID 10505978 DOI: 10.1016/S0165-5728(99)00120-4  0.8
1999 Schmidt S. Candidate autoantigens in multiple sclerosis Multiple Sclerosis. 5: 147-160. PMID 10408714  0.8
1999 Schmidt S, Hertfelder HJ, Von Spiegel T, Hering R, Harzheim M, Lassmann H, Deckert-Schlüter M, Schlegel U. Lethal capillary leak syndrome after a single administration of interferon beta-1b Neurology. 53: 220-222. PMID 10408566  0.8
1999 Schmidt U, Harrer G, Biller A, Schmidt S. A long-term, change-over study with the St John's wort extract LoHyp-57. An observational study of 95 patients with mild and moderate depression | Langzeit- und umstellungs-untersuchung mit dem Johanniskrautextrakt LoHyp-57. Anwendungsbeobachtung an 95 patienten mit leichter und mittelgradiger depression Nervenheilkunde. 18: 106-109.  0.8
1998 Schmidt S. S100B: Pathogenetic and pathophysiological implications in neurology | S100B: Pathogenetische und pathophysiologische bedeutung in der neurologie Nervenarzt. 69: 639-646. PMID 9757414 DOI: 10.1007/s001150050323  0.8
1998 Zipp F, Kerschensteiner M, Dornmair K, Malotka J, Schmidt S, Bender A, Giegerich G, de Waal Malefyt R, Wekerle H, Hohlfeld R. Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. Brain : a Journal of Neurology. 121: 1395-407. PMID 9712003 DOI: 10.1093/brain/121.8.1395  0.8
1998 Schmidt S, Padberg F. Late onset immunodeficiency in a patient with recurrent thymic carcinoma and myasthenia gravis Journal of the Neurological Sciences. 157: 201-205. PMID 9619646 DOI: 10.1016/S0022-510X(98)00085-9  0.8
1997 Schmidt S, Linington C, Zipp F, Sotgiu S, de Waal Malefyt R, Wekerle H, Hohlfeld R. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Brain : a Journal of Neurology. 120: 1437-45. PMID 9278633 DOI: 10.1093/brain/120.8.1437  0.8
1996 Schmidt S, Hohlfeld R. Current treatment of Multiple Sclerosis. Treatment with anti-T cell antibodies (CD3, CD4, CD52) | AKTUELLE THERAPIE DER MULTIPLEN SKLEROSE. THERAPIE MIT MONOKLONALEN ANTIKORPERN GEGEN T-ZELLANTIGENE (CD3, CD4, CD52) Nervenarzt. 67: 170-176. PMID 8851300  0.8
1995 Schmidt S, Reiter-Owona I, Hotz M, Mewes J, Biniek R. An unusual case of central nervous system cryptococcosis Clinical Neurology and Neurosurgery. 97: 23-27. PMID 7788968 DOI: 10.1016/0303-8467(94)00063-C  0.8
1995 Hohlfeld R, Meinl E, Weber F, Zipp F, Schmidt S, Sotgiu S, Goebels N, Voltz R, Spuler S, Iglesias A. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis Neurology. 45: S33-38. PMID 7783909 DOI: 10.1212/WNL.45.6_Suppl_6.S33  0.8
1995 Schmidt S, Hohlfeld R. Current treatment of multiple sclerosis; are there indications for intravenous immunoglobulins? | AKTUELLE THERAPIE DER MULTIPLEN SKLEROSE: GIBT ES INDIKATIONEN FUR INTRAVENOSE IMMUNGLOBULINE? Nervenarzt. 66: 304-307. PMID 7783819  0.8
1995 Schmidt S, Schmitz-Buhl M. Signs and symptoms of carbamazepine overdose Journal of Neurology. 242: 169-173. PMID 7751861 DOI: 10.1007/BF00936891  0.8
1994 Schmidt S, Wisser R, Heitmann R. Psychosomatic aspects of focal dystonia: Report of two cases | PSYCHOSOMATISCHE ASPEKTE FOKALER DYSTONIEN: ZWEI FALLBEISPIELE Ppmp Psychotherapie Psychosomatik Medizinische Psychologie. 44: 247-250. PMID 7938371  0.8
1993 Schmidt S, Cordt-Schlegel A, Heitmann R. Guillain-Barré syndrome during treatment with ofloxacin Journal of Neurology. 240: 506-507. PMID 8263558 DOI: 10.1007/BF00874121  0.8
1993 Schmidt S, Schindler E. Transverse cervical and thoracic spinal cord lesions misdiagnosed as Guillain-Barre syndrome. Report of 6 cases | FEHLDIAGNOSE POLYNEURITIS GUILLAIN-BARRE BEI ZERVIKALEN UND THORAKALEN QUERSCHNITTSYNDROMEN. BERICHT UBER 6 FALLE Nervenheilkunde. 12: 458-463.  0.8
1993 Schmidt S, Christian R, Heitmann R. Isolated impairment of learning following CO-poisoning: A neuropsychological case report | ISOLIERTE LERNSTORUNG ALS FOLGE EINER CO-INTOXIKATION. EINE NEUROPSYCHOLOGISCHE FALLSTUDIE Nervenheilkunde. 12: 222-226.  0.8
Show low-probability matches.